Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.
2.

Crystal structures of ryanodine receptor SPRY1 and tandem-repeat domains reveal a critical FKBP12 binding determinant.

Yuchi Z, Yuen SM, Lau K, Underhill AQ, Cornea RL, Fessenden JD, Van Petegem F.

Nat Commun. 2015 Aug 6;6:7947. doi: 10.1038/ncomms8947.

3.

Methods for labeling skeletal muscle ion channels site-specifically with fluorophores suitable for FRET-based structural analysis.

Mahalingam M, Fessenden JD.

Methods Enzymol. 2015;556:455-74. doi: 10.1016/bs.mie.2014.11.049. Epub 2015 Mar 20.

PMID:
25857795
4.

FRET-based trilateration of probes bound within functional ryanodine receptors.

Svensson B, Oda T, Nitu FR, Yang Y, Cornea I, Chen-Izu Y, Fessenden JD, Bers DM, Thomas DD, Cornea RL.

Biophys J. 2014 Nov 4;107(9):2037-48. doi: 10.1016/j.bpj.2014.09.029.

5.

Structural mapping of divergent regions in the type 1 ryanodine receptor using fluorescence resonance energy transfer.

Mahalingam M, Girgenrath T, Svensson B, Thomas DD, Cornea RL, Fessenden JD.

Structure. 2014 Sep 2;22(9):1322-1332. doi: 10.1016/j.str.2014.07.003. Epub 2014 Aug 14.

6.

Site-specific labeling of the type 1 ryanodine receptor using biarsenical fluorophores targeted to engineered tetracysteine motifs.

Fessenden JD, Mahalingam M.

PLoS One. 2013 May 28;8(5):e64686. doi: 10.1371/journal.pone.0064686. Print 2013.

7.

N-terminal and central segments of the type 1 ryanodine receptor mediate its interaction with FK506-binding proteins.

Girgenrath T, Mahalingam M, Svensson B, Nitu FR, Cornea RL, Fessenden JD.

J Biol Chem. 2013 May 31;288(22):16073-84. doi: 10.1074/jbc.M113.463299. Epub 2013 Apr 12.

8.

FRET-based localization of fluorescent protein insertions within the ryanodine receptor type 1.

Raina SA, Tsai J, Samsó M, Fessenden JD.

PLoS One. 2012;7(6):e38594. doi: 10.1371/journal.pone.0038594. Epub 2012 Jun 13.

9.
10.

The ryanodine receptor pore blocker neomycin also inhibits channel activity via a previously undescribed high-affinity Ca(2+) binding site.

Laver DR, Hamada T, Fessenden JD, Ikemoto N.

J Membr Biol. 2007 Dec;220(1-3):11-20. Epub 2007 Sep 18.

PMID:
17879109
11.

Amino acid residues Gln4020 and Lys4021 of the ryanodine receptor type 1 are required for activation by 4-chloro-m-cresol.

Fessenden JD, Feng W, Pessah IN, Allen PD.

J Biol Chem. 2006 Jul 28;281(30):21022-31. Epub 2006 May 31.

12.

Structural determinants of 4-chloro-m-cresol required for activation of ryanodine receptor type 1.

Jacobson AR, Moe ST, Allen PD, Fessenden JD.

Mol Pharmacol. 2006 Jul;70(1):259-66. Epub 2006 Apr 6.

PMID:
16601083
13.

Conformational activation of Ca2+ entry by depolarization of skeletal myotubes.

Cherednichenko G, Hurne AM, Fessenden JD, Lee EH, Allen PD, Beam KG, Pessah IN.

Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15793-8. Epub 2004 Oct 25.

14.

Mutational analysis of putative calcium binding motifs within the skeletal ryanodine receptor isoform, RyR1.

Fessenden JD, Feng W, Pessah IN, Allen PD.

J Biol Chem. 2004 Dec 17;279(51):53028-35. Epub 2004 Oct 6.

15.

Evidence for conformational coupling between two calcium channels.

Paolini C, Fessenden JD, Pessah IN, Franzini-Armstrong C.

Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12748-52. Epub 2004 Aug 13.

16.

Identification of a key determinant of ryanodine receptor type 1 required for activation by 4-chloro-m-cresol.

Fessenden JD, Perez CF, Goth S, Pessah IN, Allen PD.

J Biol Chem. 2003 Aug 1;278(31):28727-35. Epub 2003 May 21.

17.

Ryanodine receptor point mutant E4032A reveals an allosteric interaction with ryanodine.

Fessenden JD, Chen L, Wang Y, Paolini C, Franzini-Armstrong C, Allen PD, Pessah IN.

Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2865-70. Epub 2001 Feb 13.

18.

Divergent functional properties of ryanodine receptor types 1 and 3 expressed in a myogenic cell line.

Fessenden JD, Wang Y, Moore RA, Chen SR, Allen PD, Pessah IN.

Biophys J. 2000 Nov;79(5):2509-25.

19.

HSV-1 amplicon vectors are a highly efficient gene delivery system for skeletal muscle myoblasts and myotubes.

Wang Y, Fraefel C, Protasi F, Moore RA, Fessenden JD, Pessah IN, DiFrancesco A, Breakefield X, Allen PD.

Am J Physiol Cell Physiol. 2000 Mar;278(3):C619-26.

20.

Cyclic GMP-dependent protein kinase-I in the guinea pig cochlea.

Tian F, Fessenden JD, Schacht J.

Hear Res. 1999 May;131(1-2):63-70.

PMID:
10355605
21.

Nitric oxide/cyclic guanosine monophosphate pathway in the peripheral and central auditory system of the rat.

Fessenden JD, Altschuler RA, Seasholtz AF, Schacht J.

J Comp Neurol. 1999 Feb 1;404(1):52-63.

22.

The nitric oxide/cyclic GMP pathway: a potential major regulator of cochlear physiology.

Fessenden JD, Schacht J.

Hear Res. 1998 Apr;118(1-2):168-76. Review.

PMID:
9606072
24.

Detection and characterization of nitric oxide synthase in the mammalian cochlea.

Fessenden JD, Coling DE, Schacht J.

Brain Res. 1994 Dec 30;668(1-2):9-15. Erratum in: Brain Res 1995 Mar 27;675(1-2):394.

Supplemental Content

Loading ...
Support Center